Veterinary Vaccines Market: Global Industry Analysis and Forecast (2022-2029)

Veterinary Vaccines Market was valued at US$ 10.86 Bn. in 2021, and it is expected to reach US$ 17.56 Bn. by 2029, exhibiting a CAGR of 7.11% during the forecast period 2022-2029.

Global Veterinary Vaccines Market Overview:

The sale of vaccines and related services that are used for the treatment and prevention of illnesses in animals makes up the veterinary vaccines market. These veterinary vaccines lessen the suffering of animals and the spread of pathogens among animals. Veterinary vaccinations are used to boost an animal's immune system by promoting animal health, which also stops infections from spreading from animals to people. Veterinary Vaccines MarketTo know about the Research Methodology :- Request Free Sample Report The report explores the Veterinary Vaccines Market's segments (Animal Type, Product, Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2020. The report investigates the Veterinary Vaccines Market’s drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Veterinary Vaccines Market's contemporary competitive scenario.

Veterinary Vaccines Market Dynamics:

The growing number of zoonotic illnesses that might harm humans will probably increase demand for animal vaccinations. Food security is being threatened by new and exotic animal diseases, which pose an increasing threat to both human and animal health. Pathogen transmission within and across species is made easier by the increase in both human and animal populations, environmental deterioration, and globalization trade and travel. Massive obstacles are today and, in the future, posed by the ensuing illnesses. The majority of the world has seen an increase in commercial food animal production as a result of greater demand for animal protein. The public's health is seriously threatened by newly emerging zoonotic illnesses in both companion and livestock animals. Animal vaccines prevent the spread of diseases, protecting both the health of animals and people, which is crucial given the general public's reliance on animals. Animals are a significant source of food, milk, protein, and other industrial goods like wool and leather. The most widely used veterinary vaccines for preventing the spread of infectious illnesses by imitating naturally acquired immunity include those for rabies, foot-and-mouth disease, and equine influenza virus. With more animal diseases emerging, it is imperative that vaccinations continue to be developed. The market's expansion has been markedly enhanced by the rise in pet ownership. Due to rising pet ownership in industrialized nations and an increase in the number of cattle and poultry in emerging nations, the market for animal vaccines is anticipated to grow steadily. The market for animal vaccinations is also growing as a result of an increase in investment in vaccine R&D that prevents the development of antibiotic-resistant pathogens. For instance, Elanco allocated two-thirds of the food-animal unit's budget in August 2016 to the development of vaccines and the reduction of antibiotic use. In addition, the increased demand for animal vaccines has resulted in the development of numerous new vaccines. For instance, Ceva introduced Cevac IBron, a novel vaccine that protects against the infectious bronchitis virus, in February 2017. (IBV). The need for animal vaccines for the livestock population is rising as a result of growing concerns about food security and improved animal husbandry. Global livestock output has increased as a result of rising consumer demand for animal products. The demand for livestock products is also rising as a result of a number of factors, including population growth and variations in food preferences brought on by changing lifestyles. These factors are helpful in the growth of the market. Additionally, the ongoing development of vaccinations and the spread of cattle diseases have contributed to the changing market dynamics. Drivers: Adoption of companion animals has increased significantly in recent years. Pets are loved as members of the family and make excellent elderly companions. The market will advance as a result of increased pet adoption, which will increase demand for animal vaccines. Additionally, the market for veterinary-animal vaccines will grow as pet healthcare costs continue to rise. Additionally, a significant factor that will contribute to the development of the market's growth is the rise in the occurrence of zoonotic and foodborne infections. The market for veterinary-animal vaccinations will develop as a result of an increase in supportive government initiatives and rising consumer demand for food products produced from animals. The growth rate of the veterinary-animal vaccines market would be positively impacted by additional variables such as the rise in the demand for animal protein in human diet and the rising trend of adopting companion animals. The market for veterinary animal vaccinations will also grow as a result of increased disposable income and changing lifestyles. The market for veterinary vaccines is being driven by the rise in the number of animals suffering from a variety of diseases and the desire for vaccines to prevent and treat those diseases. Around 3300 new TB herd incidences were discovered in England, according to estimates from a statement by the Animal and Plant Health Agency. Bovine TB is a chronic infection that typically affects cattle, though it can affect all mammals as well. It causes a generalized illness, coughing, and can ultimately result in death. Specific medications that eradicate the TB germs can, however, be used to treat the illness. The market for veterinary vaccines is anticipated to be driven over the forecast period by the increased occurrence of illnesses in animals. Restrain: The market for veterinary animal vaccines will have slower growth due to high vaccination costs, a lack of well-established infrastructure in low-income countries, and limited resources for vaccine development. The growth of the veterinary-animal vaccines market would also be hampered by the low investment in pet healthcare. Opportunities: A new stage in vaccine technology is represented by DNA-based vaccines. In the world of veterinary medicine, this method is quite useful. DNA vaccines have already gained traction in a number of veterinary medical specialties. The efficacy and cost-effectiveness of the immunization in relation to already existing alternatives are two major issues that must be considered while developing DNA vaccines for animals. How to use this new technology in a range of situations, from domestic pets to individual fish in fisheries with thousands of animals to wildlife disease management programs, is another important topic that has to be covered. DNA vaccines present an intriguing alternative to current immunization techniques in some circumstances, but not in others. A range of veterinary diseases, advancements in DNA vaccine technology that are pertinent to these diseases, and their interactions with available conventional treatment options. Live, attenuated bacteria or viruses are frequently utilized in traditional immunizations that are now administered to humans or animals. Contrarily, conventional attenuation methods rely on haphazard, spontaneous changes that happen over a number of passes, and the reason for the attenuation is often not known. An alternative strategy is to utilize genetic engineering to isolate particular genes or regions of the genome that are crucial for virulence, then delete them to produce a replicating, non-pathogenic virus that can be used as an immunogen. With bacteria and large-genome DNA viruses like herpes and poxviruses, this tactic has proven to be particularly efficient. Challenges: The market will face challenges during the forecast period due to decreased knowledge of animal health issues and the potential for negative effects of veterinary vaccinations on human and other animal health. COVID - 19 Impact Veterinary Vaccines Market The COVID-19 epidemic has had a negative impact on the market. In order to stop the spread of COVID-19, for instance, nations all over the world implemented national lockdowns to follow social segregation. This caused disruption, constrictions, difficulties, and adjustments in every industry's sector. The pandemic also had an influence on the animal vaccinations sector. For instance, veterinary groups from all over the world have suggested restricting the care provided to animals to those who are seriously ill and in emergencies. Additionally, due to the lockdowns, annual physicals and optional vaccinations had to be rescheduled. However, a number of important parties have made sure that there is an adequate supply of animal vaccines since governmental organizations all over the world are taking careful efforts to maintain the supply in order to prevent the spread of zoonotic diseases into communities. However, due to a decline in demand as a result of fewer veterinarian visits and a shift in the animal healthcare paradigm toward treating severely ill and emergency patients, the overall impact of COVID-19 on the market for animal vaccinations is still largely unfavorable.

Global Veterinary Vaccines Market Segment Analysis:

Based on Product, Attenuated Vaccine segment is dominating the market with highest CAGR during the forecast period. By triggering a variety of immune responses, attenuated vaccinations can offer better immunity compared to other vaccines. Additionally, it promotes a long-lasting and quick onset of immunity, which reduces the need for booster vaccines that can be given orally and positively influences the expansion of the market for animal vaccines. Veterinary Vaccines Market Based on Animal Type, Livestock animal segment is dominating the market with highest CAGR during the forecast period. Due to rising meat, milk, and dairy product consumption and the importance of animal health in disease control, the livestock sector generated the largest amount of money in 2020 for the expansion of the animal vaccines market. However, the companion animal market is anticipated to develop at the highest rate because many of these animals frequently come into touch with people and diseases like rabies can also damage people. Additionally, a surge in the adoption of these companion animals and knowledge of the necessity of vaccinating dogs and cats are both contributing to the market's expansion.

Veterinary Vaccines Market Regional Insights:

North America region dominated the market with xx% share in 2021. The North America region is expected to witness significant growth at a CAGR of xx% through the forecast period. The largest market share is held by North America. The Animal and Plant Health Inspection Service's Center for Veterinary Biologics (CVB) oversees the regulation of veterinary vaccinations in the United States (APHIS). Animal health companies are granted establishment and product licenses by the CVB in order to produce and market veterinary biologics. The creation of live vector vaccines, non-replicating recombinant antigen vaccines, nucleic acid-mediated vaccines, and live-gene-deleted vaccinations are examples of developments in vaccine development in the United States. For instance, in January 2020, Zoetis, a renowned animal health business, added Poulvac Procerta HVT-ND, a vectored recombinant vaccine for defence against Newcastle and Marek's disease viruses, to their chicken vaccine line-up. In the world market for animal vaccinations, North America generated the most income. This is due to the widespread adoption of pets as companions, an increase in the consumption of meat and dairy products, and a growth in public understanding of the advantages of utilizing animal vaccines. Due to rising pet ownership and the prevalence of numerous zoonotic diseases, Asia-Pacific has a sizable market that could have an impact on market trends for animal vaccinations. Additionally, due to the high demand for companion animals and food products made from animals, continuous research on novel vaccine production technologies has increased. The creation of novel vaccines has also improved as a result of an increase in investments in animal healthcare firms. The objective of the report is to present a comprehensive analysis of the Global Veterinary Vaccines Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Global Veterinary Vaccines Market dynamic, structure by analyzing the market segments and projecting the Global Veterinary Vaccines Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Veterinary Vaccines Market make the report investor’s guide.

Veterinary Vaccines Market Scope: Inquire before buying

Global Veterinary Vaccines Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US$ 10.86 Bn.
Forecast Period 2022 to 2029 CAGR: 7.11% Market Size in 2029: US$ 17.56 Bn.
Segments Covered: by Animal Type • Companion animal o Dogs o Cats • Livestock animal o Cattle o Pigs o Poultry o Sheep o Others • Aquaculture
by Product • Attenuated Vaccines • Inactivated Vaccines • Subunit Vaccines • Toxoid Vaccines • Conjugate Vaccines • Recombinant Vaccines • DNA Vaccines

Veterinary Vaccines Market by Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Veterinary Vaccines Market Key Players

• Merck & Co., Inc. • Zoetis • Boehringer Ingelheim International GmbH • Virbac • Biogénesis Bagó • Indian Immunologicals Ltd. • Elanco • Ceva • Phibro Animal Health Corporation • Neogen Corporation • Intas Pharmaceuticals Ltd. • Ourofino Saúde Animal • Bayer AG • Sanofi • Pfizer Inc. • GlaxoSmithKline plc • Cargill, Incorporated • Takeda Pharmaceutical Company Limited • Eli Lilly and Company • Vetoquinol • Dechra Pharmaceuticals PLC • Indovax Frequently Asked Questions: 1] What segments are covered in the Global Veterinary Vaccines Market report? Ans. The segments covered in the Global Veterinary Vaccines Market report are based on Animal Type, Product, and End User. 2] Which region is expected to hold the highest share in the Veterinary Vaccines Market? Ans. North America region is expected to hold the highest share in the Global Veterinary Vaccines Market. 3] What is the market size of the Global Veterinary Vaccines Market by 2029? Ans. The market size of the Global Veterinary Vaccines Market by 2029 is expected to reach US$ 17.56 Bn. 4] What is the forecast period for the Global Veterinary Vaccines Market? Ans. The forecast period for the Global Veterinary Vaccines Market is 2021-2029. 5] What was the market size of the Global Veterinary Vaccines Market in 2021? Ans. The market size of the Global Veterinary Vaccines Market in 2021 was valued at US$ 10.86 Bn.
1. Global Veterinary Vaccines Market: Research Methodology 2. Global Veterinary Vaccines Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Veterinary Vaccines Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Veterinary Vaccines Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Veterinary Vaccines Market Segmentation 4.1 Global Veterinary Vaccines Market, By Product (2021-2029) • Attenuated Vaccines • Inactivated Vaccines • Subunit Vaccines • Toxoid Vaccines • Conjugate Vaccines • Recombinant Vaccines • DNA Vaccines 4.2 Global Veterinary Vaccines Market, By Animal Type (2021-2029) • Companion animal • Dogs • Cats • Livestock animal • Cattle • Pigs • Poultry • Sheep • Others • Aquaculture 5. North America Veterinary Vaccines Market (2021-2029) 5.1 North America Veterinary Vaccines Market, By Product (2021-2029) • Attenuated Vaccines • Inactivated Vaccines • Subunit Vaccines • Toxoid Vaccines • Conjugate Vaccines • Recombinant Vaccines • DNA Vaccines 5.2 North America Veterinary Vaccines Market, By Animal Type (2021-2029) • Companion animal • Dogs • Cats • Livestock animal • Cattle • Pigs • Poultry • Sheep • Others • Aquaculture 5.3 North America Veterinary Vaccines Market, by Country (2021-2029) • United States • Canada • Mexico 6. Asia Pacific Veterinary Vaccines Market (2021-2029) 6.1. Asia Pacific Veterinary Vaccines Market, By Product (2021-2029) 6.2. Asia Pacific Veterinary Vaccines Market, By Animal Type (2021-2029) 6.3. Asia Pacific Veterinary Vaccines Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Veterinary Vaccines Market (2021-2029) 7.1 Middle East and Africa Veterinary Vaccines Market, By Product (2021-2029) 7.2. Middle East and Africa Veterinary Vaccines Market, By Animal Type (2021-2029) 7.3. Middle East and Africa Veterinary Vaccines Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Veterinary Vaccines Market (2021-2029) 8.1. Latin America Veterinary Vaccines Market, By Product (2021-2029) 8.2. Latin America Veterinary Vaccines Market, By Animal Type (2021-2029) 8.3. Latin America Veterinary Vaccines Market, by Country (2021-2029) • Brazil • Argentina • Rest of Latin America 9. European Veterinary Vaccines Market (2021-2029) 9.1. European Veterinary Vaccines Market, By Product (2021-2029) 9.2. European Veterinary Vaccines Market, By Animal Type (2021-2029) 9.3. European Veterinary Vaccines Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest of Europe 10. Company Profile: Key players 10.1. Merck & Co., Inc 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Zoetis 10.3 Boehringer Ingelheim International GmbH 10.4 Virbac 10.5 Biogénesis Bagó 10.6 Indian Immunologicals Ltd. 10.7 Elanco 10.8 Ceva 10.9 Phibro Animal Health Corporation 10.10 Neogen Corporation 10.11 Intas Pharmaceuticals Ltd. 10.12 Ourofino Saúde Animal 10.13 Bayer AG 10.14 Sanofi 10.15 Pfizer Inc. 10.16 GlaxoSmithKline plc 10.17 Cargill, Incorporated 10.18 Takeda Pharmaceutical Company Limited 10.19 Eli Lilly and Company 10.20 Vetoquinol 10.21 Dechra Pharmaceuticals PLC 10.22 Indovax

About This Report

Report ID 6675
Category Healthcare
Published Date July 2022
Updated Date
Contact Us